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View OnlineDetermination of intracellular glutathione and glutathione disulfide using high
performance liquid chromatography with acidic potassium permanganate
chemiluminescence detection†
Geoffrey P. McDermott,a Paul S. Francis,*a Kayla J. Holt,a Kristen L. Scott,a Sheree D. Martin,b
Nicole Stupka,b Neil W. Barnetta and Xavier A. Conlan*b
Received 4th January 2011, Accepted 8th February 2011
DOI: 10.1039/c1an00004gMeasurement of glutathione (GSH) and glutathione disulfide (GSSG) is a crucial tool to assess cellular
redox state. Herein we report a direct approach to determine intracellular GSH based on a rapid
chromatographic separation coupled with acidic potassium permanganate chemiluminescence
detection, which was extended to GSSG by incorporating thiol blocking and disulfide bond reduction.
Importantly, this simple procedure avoids derivatisation of GSH (thus minimising auto-oxidation) and
overcomes problems encountered when deriving the concentration of GSSG from ‘total GSH’. The
linear range and limit of detection for both analytes were 7.5  107 to 1  105 M, and 5  107 M,
respectively. GSH and GSSG were determined in cultured muscle cells treated for 24 h with glucose
oxidase (0, 15, 30, 100, 250 and 500 mU mL1), which exposed them to a continuous source of reactive
oxygen species (ROS). Both analyte concentrations were greater in myotubes treated with 100 or 250
mU mL1 glucose oxidase (compared to untreated controls), but were significantly lower in myotubes
treated with 500 mU mL1 (p< 0.05), which was rationalised by considering measurements of H2O2 and
cell viability. However, the GSH/GSSG ratio in myotubes treated with 100, 250 and 500 mU mL1
glucose oxidase exhibited a dose-dependent decrease that reflected the increase in intracellular ROS.Introduction
Beginning with the early observations of Sir Frederick Gowland
Hopkins in the 1920s,1–3 glutathione (GSH; L-g-glutamyl-L-
cycteinyl-glycine; Fig. S1a, ESI†) has been extensively studied by
researchers from a diverse range of disciplines.4–10 Investigations
have primarily focused on the many biochemical properties of
GSH as it is the major low molecular weight antioxidant species
present in eukaryotic cells, and a regulator of protein and cell
functionality.4,5,8–11 In its capacity as an antioxidant, GSH has
the potential to reduce free radicals and reactive oxygen species
(ROS), which results in the formation of the corresponding
disulfide (GSSG, Fig. S1b, ESI†).4,5,8–11 To complete this intra-
cellular redox cycle, GSH is regenerated by the enzymeaSchool of Life and Environmental Sciences, Deakin University, Geelong,
Victoria, 3217, Australia. E-mail: psf@deakin.edu.au; Tel: +61 3 5227
1294
bInstitute for Technology Research and Innovation, Deakin University,
Geelong, Victoria, 3217, Australia. E-mail: xavier@deakin.edu.au; Tel:
+61 3 5227 1416
† Electronic supplementary information (ESI) available: Optimisation of
acidic potassium permanganate chemiluminescence detection, GSSG
reduction, and GSH alkylation reaction conditions. GSH and GSSG
calibration plots and analytical figures of merit, instrumental setup,
summary of GSH and GSSG detection and additional materials and
methods. See DOI: 10.1039/c1an0004g
2578 | Analyst, 2011, 136, 2578–2585glutathione reductase in a NADPH dependent reaction.4,5,8–11
The molar ratio of GSH/GSSG in a cell is typically between
10 : 1 and 1000 : 1; however, under oxidative stress, this ratio
decreases.5,8,10,12,13 Since oxidative stress has been implicated in
a growing number of pathological and physiological condi-
tions,5,14–16 assessing redox state is an invaluable tool for many
researchers.4,5,8–10,12,13,17–22
The importance of GSH and GSSG measurement for the
assessment of redox state is reflected by the plethora of analytical
methodologies, including liquid chromatography, gas chroma-
tography or capillary electrophoresis separation with fluores-
cence, electrochemical, mass spectrometry or UV absorbance
detection, which are the subject of numerous reviews.8,12,13,17–22
As identified in these reviews and other papers, there are several
major analytical challenges associated with the measurement of
GSH and GSSG.8,12,13,18–38 Firstly, neither contain a strong
chromophore or fluorophore. This problem is most often
addressed by derivatisation of GSH, but the reactions are time-
consuming (up to 60 min) and can add a significant source of
error.8,12,13,18,20–24,26,27,31,34,38 GSSG is then measured by reducing
its disulfide bond and subjecting the liberated GSH to the same
derivatisation procedure.8,12,13,20–22 Secondly, GSH is easily oxi-
dised under the alkaline conditions employed for derivatisation
and some other sample pre-treatment steps,8,12,13,19,21,25,28–30,32–37
which can result in artificially high GSSG concentrations.This journal is ª The Royal Society of Chemistry 2011
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View OnlineFinally, GSH and GSSG can occur at very low levels (below the
limits of detection of some techniques), and GSSG is often
present several orders of magnitude lower in concentration than
GSH.
Methodologies that employ direct detection and minimal
sample handling are therefore more desirable. Electron spin
resonance, nuclear magnetic resonance, electrochemical, UV
absorbance, fluorescence quenching or mass spectroscopy have
been utilised to determine GSH (and in some cases GSSG)
without derivatisation, as summarised in the following selected
references.8,12,13,17,20,22,39–41 However, these approaches suffer
from limitations in terms of performance, equipment costs,
complexity, sensitivity and/or analysis time. An often overlooked
alternative for the direct measurement of GSH is chem-
iluminescence,42–49 which offers highly sensitive detection using
relatively simple instrumentation.50–54 Beginning in 1984, Hinze
et al.45 reported the detection of GSH and several other biolog-
ically significant reductants based on the chemiluminescence
reaction with lucigenin, but they primarily focused on the effect
of micellar systems upon the emission. Several subsequent
publications have described the determination of GSH using
batch or flow-injection analysis with chemiluminescence detec-
tion based on (i) enhancement of the emission from the oxidation
of luminol,42,43,48 (ii) quinine sensitised emission from the
oxidation of the analyte,46,47 or (iii) reaction with permanganate
and tris(1,10-phenanthroline)ruthenium(II).44 Preliminary appli-
cations to several blood samples showed a reasonable agreement
with a spectrophotometric assay,43,48 but without chromato-
graphic or electrophoretic separation, these methods lack the
selectivity required to accurately measure GSH in complex
biological matrices. One attempt to address this issue was
recently described by Zhao et al.,49 who determined GSH and
other intracellular thiols by microchip electrophoresis with
luminol chemiluminescence. The method was applied to single
red blood cells from healthy subjects and cancer patients, but the
sensitivity was not sufficient to quantify GSH in some samples.
Furthermore, none of the chemiluminescence-based procedures
reported to date have included strategies for GSSG detection,
which is essential to establish cellular redox state.
Herein we describe the determination of intracellular GSH and
GSSG based on a rapid chromatographic separation coupled
with post-column acidic potassium permanganate chem-
iluminescence detection. For direct GSH measurement, samples
were simply diluted into an acidic solution prior to injection onto
the column. In a separate analysis step, GSSG was quantified by
masking endogenous thiols, disulfide bond reduction, and
detection of the newly formed GSH. Furthermore, this approach
was utilised to assess the redox state of cultured muscle cells
(C2C12 myotubes) treated with various concentrations of
glucose oxidase, which causes oxidative stress through the
continuous production of hydrogen peroxide.Materials and methods
Flow injection analysis
A conventional FIA manifold with a chemiluminescence detector
was constructed in our laboratory. A peristaltic pump (Gilson
Minipuls 3, John Morris Scientific, Balwyn, Victoria, Australia)This journal is ª The Royal Society of Chemistry 2011with bridged PVC tubing (DKSH, Caboolture, Queensland,
Australia) was used to propel solutions through 0.8 mm i.d.
PTFE tubing (DKSH). Standards (1  105 M) were injected
(70 mL) with an automated six-port valve (Valco Instruments,
Houston, Texas, USA) into a carrier stream (100% methanol
unless otherwise stated), which merged with a solution of acidic
potassium permanganate at a T-piece, and the light emitted from
the reacting mixture was detected with a custom built
flow-through luminometer, as described in the following
sub-section. The output from the photomultiplier was docu-
mented with a chart recorder (YEW type3066, Yokogawa
Hokushin Electric, Tokyo, Japan).High performance liquid chromatography
Chromatographic analysis was carried out on an Agilent
Technologies 1200 series liquid chromatography system, equip-
ped with a quaternary pump, a solvent degasser system and an
autosampler (Agilent Technologies, Forest Hill, Victoria,
Australia). Hewlett-Packard Chemstation software (Agilent
Technologies) was used to control the HPLC pump and acquire
data from the chemiluminescence detector. Before use in the
HPLC system, all sample solutions and solvents were filtered
through a 0.45 mm nylon membrane.
Post-column acidic potassium permanganate chem-
iluminescence was generated using the manifold outlined in
Fig. S2, ESI†. The reagent, propelled at a flow rate of 2.5 mL
min1 using a Gilson Minipuls 3 peristaltic pump (John Morris
Scientific, Balwyn, Victoria, Australia) with bridged PVC tubing
(DKSH), merged with the HPLC eluant at a T-piece and the light
emitted from the reacting mixture was detected with a custom
built flow-through luminometer, which consisted of a coiled flow
cell comprising of 0.8 mm i.d. PTFE tubing (DKSH), mounted
flush against the window of Electron Tubes photomultiplier tube
(model 9828SB, ETP) set at a constant voltage of 900 V from
a stable power supply (PM20D, ETP) via a voltage divider (C611,
ETP). The flow cell, photomultiplier tube and voltage divider
were encased in a padded light-tight housing, and a Hewlett-
Packard analogue to digital interface box (Agilent Technologies)
was used to convert the signal from the chemiluminescence
detector.Cell culture and glucose oxidase treatment
Mouse C2C12 myoblasts were maintained in Dulbecco’s modi-
fied Eagle’s medium (DMEM, 5.5 mM glucose) supplemented
with 10% fetal bovine serum (FBS) at 37 C and 5% CO2. To
stimulate myotube formation, myoblasts were grown to conflu-
ence and then transferred to DMEM supplemented with 2%
horse serum (HS). For determination of GSH and GSSG
content, cells were grown in 6-well tissue culture plates, and for
the oxidative stress and viability assays cells were grown in
96-black well, clear bottom tissue culture plates. To induce
oxidative stress, C2C12 myotubes at 4 d post-differentiation were
treated with 0, 30, 100, 250 or 500 mU mL1 glucose oxidase in
50 mM sodium acetate buffer (pH 5.1) for 24 h. Glucose oxidase
increases ROS levels in the cell culture medium by catalysing the
oxidation of glucose to produce D-glucono-d-lactone and
H2O2.
55,56 This exposed the myotubes to a continuous, moreAnalyst, 2011, 136, 2578–2585 | 2579
‡ Rossi et al. caution against acidification of blood samples as they found
it can lead to significant GSH oxidation by unidentified reaction(s) with
oxyhemoglobin. Alternatively they suggest blocking the free thiol moiety
of GSH using an alkylating agent such as NEM prior to acidification of
blood (see ref. 36).
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View Onlinebiologically relevant source of ROS (that can cross the cell
membrane to alter intracellular redox state) than a single
concentrated, rapidly metabolised dose.55–57
Sample collection and analysis
For determination of GSH and GSSG contents, C2C12
myotubes were harvested by trypsinisation and resuspended in
200 mL of deionised water. A 35 mL aliquot was solubilised in
10% sodium dodecyl sulfate (SDS) to a final concentration of
0.2% SDS (v/v) for protein determination using the bicinchoninic
acid (BCA) method (#23225, Pierce) according to manufactur-
er’s instructions. The rest of the sample was treated with formic
acid to a final concentration of 0.5%, and stored immediately at
80 C. Prior to analysis, C2C12 myotubes were thawed on ice
and then centrifuged at 12 000 rpm for 5 min at 5 C using an
Avanti 30 Centrifuge (Beckman Coulter, Gladesville, NSW,
Australia) to remove precipitated proteins and cellular debris.
For GSH determination, 50 mL of the supernatant was diluted
into 450 mL of 5% aqueous formic acid, filtered through a 0.45
mm nylon membrane and analysed. For GSSG determination,
the supernatant (100 mL) was combined with Tris–HCl buffer
(0.675 M; 20 mL; pH 8.0) and NEM (6.3  103 M; 20 mL) and
left for one minute. Subsequently, 2-mercaptoethanol (8  103
M; 20 mL) was added and the sample left for another minute.
Then TCEP (7.8  104 M; 20 mL) was added and the solution
was left for 60 min at 50 C to allow complete disulfide reduction.
Finally, 5% aqueous formic acid (20 mL) was added, and the
sample filtered through a 0.45 mm nylon membrane and analysed.
The overall dilutions of the sample aliquots for GSH and GSSG
determinations were therefore 10-fold and 2-fold, respectively.
GSH and GSSG data are presented normalised to protein
content.
The procedures used to assess mitochondrial function (MTT
assay), membrane integrity (ethidium uptake assay) and oxida-
tive stress (H2O2 assay), and the sources of chemicals used in this
study have been included in the ESI†.
Statistical analysis
All data are presented as mean  SEM. One-way ANOVA with
Tukey post hoc analysis, when applicable, was used to assess the
effect of glucose oxidase treatment on cellular redox state,
markers of oxidative stress and cell viability.
Results and discussion
Preliminary chemiluminescence investigations
Li and co-workers reported a weak emission of light from the
oxidation of GSH with acidic potassium permanganate, which
was significantly enhanced by the addition of quinine.46 We have
previously shown that this chemiluminescence reaction involves
two interdependent light-producing pathways;58,59 the analyte is
oxidised to a intermediate capable of transferring energy to the
efficient fluorophore (lmax ¼ 458 nm), and the permanganate is
reduced to an electronically excited manganese(II) species (lmax¼
735 nm).58,59 Considering that the manganese(II) emission from
other reactions with acidic potassium permanganate have been
significantly enhanced by the addition of sodium polyphosphates2580 | Analyst, 2011, 136, 2578–2585to the reagent solution,50 we sought to use this enhancer to
promote the manganese(II) pathway. Removing the need for the
quinine would eliminate the background emission from reaction
between the sensitiser and oxidant,46,60 and enable post-column
chemiluminescence detection of GSH using a single reagent
solution.
Preliminary experiments were conducted using FIA as it
provided similar conditions to HPLC, but without the relatively
time-consuming separation. The reaction of GSH (1  105 M)
with potassium permanganate (1  103 M in 1% (w/v) sodium
polyphosphate solution, adjusted to pH 2 with sulfuric acid)
produced a large chemiluminescence response, but no signal was
recorded for the disulfide, GSSG (1  105 M). To find the
parameters that would afford the greatest chemiluminescence
response for GSH, a series of univariate searchers were
performed (Fig. S3, ESI†). These experiments showed that
a 2.5  104 M potassium permanganate solution containing
1% (w/v) sodium polyphosphates adjusted to pH 3 with sulfuric
acid, delivered at a flow rate of 2.5 mL min1 per line, was
optimal and therefore utilised in all further experiments.High performance liquid chromatography
Reverse-phase HPLC has been incorporated into many methods
for the determination of GSH, but pre-column derivatisation is
often utilised and as a consequence there are very few reports of
separations for non-derivatised GSH.12,13,20–22 In a recent review
of chromatographic and mass spectrometric analysis of biolog-
ical samples for GSH, Iwasaki et al.20 suggested that either highly
polar HPLC stationary phases (such as amino, diol) or hydro-
phobic interaction chromatography is required. However, Zhang
et al.38 reported adequate GSH retention using a more conven-
tional non-polar C18 column. Therefore, to resolve GSH from
other sample components, an optimisation of HPLC conditions
(injection volume, mobile phase composition and pH, tempera-
ture and flow rate) using a particle-packed column with either an
amino or C18 stationary phase was performed. Conditions found
to provide sufficient GSH retention in combination with
maximum acidic potassium permanganate chemiluminescence
signal are shown in Table 1. These chromatographic parameters
allowed for the complete separation of GSH from sample
components in less than 6 minutes (Fig. 1).Sample collection and preparation
Glutathione auto-oxidation in alkaline solutions and enzymatic
conversion under neutral conditions are major sources of error in
GSH measurement.8,12,13,19,21,25,28–30,32–37 Therefore, it has been
suggested by numerous authors12,13,19,20,61 that the pH of most
matrices to be analysed be kept in an acidic range.‡ Furthermore,
acidification is one approach to denature and precipitate
proteins; an important requirement for analysis.8,12,13,17,19,20,22
Although many methods involve acidification of the sample
during collection, neutral or alkaline conditions are oftenThis journal is ª The Royal Society of Chemistry 2011
Fig. 2 Strategies employed for determination of (a) GSH, (b) ‘total
Table 1 Optimised separation conditions for the determination of GSH
Injection volume 20 mL
Mobile phase 97% aqueous formic acid (pH 2.8), 3% methanol
Flow rate 1 mL min1
Column Alltech Alltima C18
(250 mm  4.6 mm i.d., 5 mm)
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View Onlineemployed for derivatisation reactions or to improve ionisation
when mass spectroscopy is used.8,12,13,20,22,26 However, since a low
pH improved both the chromatographic retention of GSH and
the intensity of the chemiluminescence emission with perman-
ganate, the standards and samples (C2C12 myoblasts) were
prepared/collected, stored and analysed in an acidic environment
(formic acid, pH 2.8). Additionally, using a commercially
available BCA protein assay kit, the amount of protein
precipitated when using formic acid was found to be similar to
the levels removed when acidifying with the more traditional
methanesulfonic acid.GSH’ (GSSG + GSH), (c) GSSG (indirect detection). *This step includes
initial removal of excess NEM.Disulfide bond reduction
As previously noted, no measurable quantity of light was
recorded from the reaction between GSSG and acidic potassium
permanganate, preventing direct detection of this species. The
same issue is encountered in methodologies that utilise
pre-column derivatisation, as appropriate chromophores or
fluorophores are introduced by reaction with the free thiol
moiety of GSH, which is absent in GSSG.8,12,13,18–22 This has been
overcome by GSSG disulfide bond reduction, which produces
two GSH molecules.8,12,13,19–22 In this approach, an initial anal-
ysis is performed to determine GSH (Fig. 2a). The sample is then
subjected to a disulfide bond reduction step before analysisFig. 1 Typical acidic potassium permanganate chemiluminescence
traces from the analysis of: (a) GSH standard (1 105 M) and (b) mouse
C2C12 myotubes (sample diluted 1 : 5 into 5% aqueous formic acid).
Chromatographic conditions described in Table 1.
This journal is ª The Royal Society of Chemistry 2011(Fig. 2b), where the signal is now a combination of endogenous
and liberated GSH (often referred to as ‘total GSH’). The GSSG
concentration is therefore the difference between the two afore-
mentioned measurements. Disulfide bond reduction employing
tris(2-carboxyethyl)phosphine (TCEP)x was explored for the
indirect determination of GSSG using the methodology outlined
in this paper, where the influence of time, temperature and pH on
the reaction was considered. It has been reported that a high
excess of reagent results in decreased reaction times.62,63
However, as our preliminary experiments showed that TCEP
also elicited chemiluminescence with permanganate, we were
limited to a final concentration no higher than 8.75  105 M to
avoid interference in the detection of GSH. Initially, GSSG
(1 105 M in aqueous formic acid, pH 2.8) was combined (1 : 1)
with TCEP (1.75  104 M in deionised water) and the resulting
solution was repeatedly injected into the HPLC over time to
monitor disulfide bond reduction through the corresponding
formation of GSH. Although this reagent reportedly reduces
disulfide bonds at low pH,64 only 50% of GSSG was reduced in
60 min. Considering the rate-limiting step in this reaction is the
attack of the disulfide bond by the phosphine nucleophile
(pKa 7.66
65), deprotonation of TCEP was postulated to greatly
enhance GSSG reduction. Therefore, GSSG (1  105 M in
aqueous formic acid, pH 2.8) was combined with TCEP (3.5 
104 M in deionised water) and a Tris–HCl buffer (0.3 M; pH 8.0)
in a 2 : 1 : 1 ratio. Aliquots of the resulting solution were taken,x Traditionally, GSSG reduction has been achieved using dithiothreitol
(DTT) or 2-mercaptoethanol. However as both of these reagents
themselves possess a free thiol moiety, cross-reactivity with derivatising
agents is reportedly an issue. This has led researchers to explore
alternative reducing agents such as TCEP. Although eliminating the
reaction between reducing and derivatising reagents was of little
consequence for this study, TCEP was selected for use as unlike DTT
and 2-mercaptoethanol it is highly water soluble, odorless, non-volatile,
non-flammable, non-corrosive and is less sensitive to air and humidity.
Analyst, 2011, 136, 2578–2585 | 2581
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View Onlinere-acidified, and injected into the HPLC over time. In this case,
approximately 80% of GSSG was reduced over 60 min. Finally,
increasing the reaction temperature to 50 C resulted in complete
disulfide reduction within 50 min (Fig. S4, ESI†).Fig. 3 Typical acidic potassium permanganate chemiluminescence
traces from the analysis of a mixture of GSH (1  105 M) and GSSG
(1  105 M) in aqueous formic acid (pH 2.8). (a) Detection of GSH. (b)
Signal after the addition of NEM and Tris–HCl buffer to the sample. (c)
Detection of GSSG after addition of 2-mercaptoethanol and TCEP to the
sample already containing NEM and Tris–HCl buffer. Experimental
parameters are described in the text above and chromatographic
conditions outlined in Table 1.Reaction (blocking) of thiol with N-ethylmaleimide
Although conditions were found that afforded complete disulfide
bond reduction, the ratio of GSH to GSSG under certain
physiological conditions may be as high as 1000 : 1, making it
analytically challenging to accurately measure small GSSG
values by subtracting one large GSH concentration from
another. Consequently, we examined an alternative approach to
the determination of GSSG, based on the methodology of
Østergaard and co-workers.66 The sample was again split into
two, with one part analysed immediately for GSH (Fig. 2a). To
the remaining fraction, the thiol alkylating reagent N-ethyl-
maleimide (NEM) was added to form a thioether derivative of
GSH that does not elicit any measurable chemiluminescence with
permanganate. GSSG is then reduced by the addition of TCEP
and the liberated GSH is detected (Fig. 2c). Not only does this
approach negate the need to examine the difference between two
similar large values, but the addition of NEM also aids in
preventing unintended oxidation of GSH. The reaction was
initially examined by combining equal volumes of GSH (1 105
M in aqueous formic acid, pH 2.8) and NEM (1.8  103 M in
deionised water), and injecting the mixture into the HPLC over
time to monitor the decrease in GSH. As can be seen in Fig. S5,
ESI†, only 80% of the GSH was blocked by NEM over 25 min.
Considering the reaction rate is dependent on thiol deprotona-
tion,19 the GSH alkylation was re-examined by combining GSH
(1  105 M in aqueous formic acid, pH 2.8) with NEM (3.6 
103 M in deionised water) and a Tris–HCl buffer (0.1 M; pH 8.0)
in a 2 : 1 : 1 ratio. Aliquots of the resulting solution were
re-acidified and injected into the HPLC over time. Although
increasing solution pH can promote auto-oxidation and
unwanted side reactions,8,12,13,19,21,25,28–30,32–37 when employing
a Tris–HCl buffer, alkylation of the GSH thiol moiety was
practically instantaneous (Fig. S5, ESI†).Removal of excess N-ethylmaleimide
Since NEM is added in excess compared to the level of free thiols,
it must be removed prior to disulfide bond reduction, to prevent
reaction with the liberated GSH. To achieve this, Østergaard
et al.66 added 2-mercaptoethanol because this thiol readily reacts
with NEM in an analogous manner to GSH. We evaluated
this approach using a mixture of GSH (1  105 M) and GSSG
(1  105 M) in aqueous formic acid (pH 2.8), which was
subjected to the protocols outlined in Fig. 2a and c. Firstly, an
aliquot of the mixture was simply filtered and analysed for GSH
(Fig. 3a). Secondly, to demonstrate the GSH thiol blocking with
NEM (Fig. 2c, step (i) only), the mixture (100 mL) was combined
with Tris–HCl buffer (0.675 M; 20 mL; pH 8.0) and NEM (6.3 
103 M; 20 mL), left for 20 s, filtered and analysed (Fig. 3b). The
disappearance of the peak at 5.1 min in this chromatogram
indicated complete reaction of GSH with NEM. Thirdly, to
quantify GSSG, the GSH thiol blocking was followed by
removal of excess NEM and disulfide bond reduction prior2582 | Analyst, 2011, 136, 2578–2585to analysis (Fig. 2c, steps (i), (ii) and (iii)). In this procedure,
2-mercaptoethanol (8 103 M; 20 mL) was added to the mixture
containing Tris–HCl buffer and NEM and left for 20 s. Next,
TCEP (7.8  104 M; 20 mL) was added and the mixture was left
for 60 min at 50 C to allow complete disulfide reduction (Fig. 2c,
step (ii)). Aqueous formic acid (5%, 20 mL) was then introduced
to re-acidify the sample before filtration and analysis. The
absence of a peak corresponding to GSH in Fig. 3b and its
appearance in Fig. 3c (equivalent to 99.7% of the predicted GSH
liberated from GSSG) confirm both the successful removal of
excess NEM and the complete reduction of GSSG. It should be
noted that although the GSSG disulfide bond reduction
produces two GSH molecules, the addition of the reagents also
diluted the sample 2-fold and therefore the peak in Fig. 3c is
similar to the peak in Fig. 3a.Analytical figures of merit
The procedure was evaluated in terms of linearity, sensitivity and
precision (Table S1, ESI†). A calibration curve for GSH
prepared using 30 standard solutions over the range of 1  107
M to 1  104 M showed an approximate linear relationship
from 7.5  107 M to 1  104 M (correlation co-efficient,
R2 ¼ 0.997). However, within the range of 7.5  107 M to 1 
105 M the calibration was highly linear with R2 ¼ 0.9999
(Fig. S6, ESI†). The limit of detection, defined as the lowest
signal detected with a signal-to-noise ratio of 3, was determined
to be 5  107 M GSH. The precision of repeated injections
(n ¼ 6) of GSH at low (1  106 M), medium (2.5  106 M) andThis journal is ª The Royal Society of Chemistry 2011
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View Onlinehigh (5  105 M) concentrations was good (R.S.D. of less than
1.5%). Similar figures of merit (Table S1, ESI†) were obtained for
the determination of GSSG following the procedure outlined in
Fig. S7, ESI†.Fig. 4 The effects of a 24 h glucose oxidase treatment on intracellular
H2O2 levels and cell viability in C2C12 myotubes. (a) Amplex Red assay
for intracellular H2O2 levels (N ¼ 1 experiment with 7 replicates); (b)
MTT activity assay to assess mitochondrial function (N ¼ 1 experiment
with 8 replicates); (c) cellular ethidium uptake to assess membrane
integrity (N ¼ 2 experiments with 7 replicates). Symbols show significant
differences at p < 0.05 (one-way ANOVA).Determination of GSH and GSSG in a biological system
The procedure (summarised in Fig. S7, ESI†) was employed to
determine GSH and GSSG in C2C12 myotubes that had been
treated for 24 h with various quantities of glucose oxidase. This
chronically exposed the myotubes to a continuous, biologically
relevant source of ROS.55–57 Hydrogen peroxide produced by the
glucose oxidase in the cell culture medium can diffuse into
myotubes through the cell membrane, where in order to maintain
redox state, it is quenched by various intracellular antioxi-
dants.55–57 However, if there is an imbalance between H2O2 influx
and antioxidant capacity, then intracellular ROS levels
(including H2O2) will increase, cell viability will decrease, and the
GSH/GSSG ratio will decrease.
Intracellular H2O2 levels were assessed using the commercially
available Amplex Red assay, which showed that there was no
significant increase in H2O2 when the cells were treated with 15 or
30 mU mL1 of glucose oxidase compared to untreated controls
(Fig. 4a). However, when myotubes were treated with 100, 250
and 500 mU mL1 glucose oxidase, cellular antioxidant defenses
were overwhelmed and a dose-dependent increase in H2O2 was
observed (p < 0.05). C2C12 myotube viability was assessed by
measuring mitochondrial function (assessed using the MTT
assay, Fig. 4b) and cell membrane integrity (based on ethidium
uptake, Fig. 4c). Both mitochondrial function and cell membrane
integrity were compromised in cells treated with 100, 250 and 500
mU mL1 glucose oxidase (p < 0.05), signifying dead or dying
cells undergoing apoptosis or necrosis. Membrane integrity was
also reduced in myotubes treated with lower quantities of glucose
oxidase (15 and 30 mU mL1; p < 0.05). This attribute is sensitive
to oxidative stress because it is exposed to increased H2O2, both
intracellular and extracellular (where there are essentially no
antioxidant molecules). Having established that glucose oxidase
treatment causes enough oxidative stress to disrupt myotube
homeostasis, the intracellular redox environment was assessed by
quantifying GSH, GSSG and their respective ratio using the
method described herein.
The concentrations of GSH and GSSG in the supernatant of
the cell lysates (corrected for protein content) are shown in Table
2. In myotubes treated with 15 mU mL1 or 30 mU mL1 glucose
oxidase, for which there was no significant increase in H2O2 or
loss of mitochondrial function, the concentrations of GSH and
GSSG were similar to the untreated cells. In myotubes treated
with 100 mU mL1 or 250 mU mL1 glucose oxidase, much
greater concentrations of GSH and GSSG were found (p < 0.05),
indicating an adaptive response to the oxidative stress stimulus.
However, when treated with 500 mU mL1 glucose oxidase, the
myotubes had lower GSH and GSSG levels than all other
treatments (Table 2; p < 0.05), presumably mediated by greater
membrane damage (Fig. 4c). The molar ratio of GSH/GSSG in
myotubes treated with 15 or 30 mU mL1 glucose oxidase was
not significantly different to that in the untreated sample (Fig. 5).
Therefore, although membrane integrity was reduced (Fig. 4c),
the myotubes maintained their cellular redox state under thisThis journal is ª The Royal Society of Chemistry 2011level of oxidative stress. However, when the concentration of
glucose oxidase was increased, a dose dependent decrease in the
GSH/GSSG ratio was observed (Fig. 5; p < 0.05), which reflected
the increase in ROS (Fig. 4a).Analyst, 2011, 136, 2578–2585 | 2583
Table 2 GSH and GSSG in mice C2C12 myotubesa
GO dose/mU
mL1
GSH/mM per 100 mg
protein
GSSG/mM per 100 mg
protein
0 8.48 (1.19)* 0.69 (0.11)*
15 5.99 (0.31)* 0.40 (0.028)*
30 6.73 (0.27)* 0.47 (0.046)*
100 14.61 (1.13)† 2.08 (0.17)‡
250 13.33 (0.57)† 2.18 (0.13)†
500 1.43 (0.40)‡ 0.36 (0.11)*
a These values are reported as means of six determinations (SEM). For
each analyte symbols show significant differences at p < 0.05 (one-way
ANOVA).
Fig. 5 GSH/GSSG ratio in myotubes treated with different quantities
of glucose oxidase (N ¼ 2 experiments in triplicate). Symbols show
significant differences at p < 0.05 (one-way ANOVA).
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View OnlineConclusions
Rapid HPLC separation coupled with direct acidic potassium
permanganate chemiluminescence detection provided a simple
and reliable approach to determine GSH, which was extended to
GSSG by incorporating thiol blocking and disulfide bond
reduction. Unlike conventional approaches with absorbance or
fluorescence detection, this procedure does not require derivati-
sation of GSH (thus minimising error associated with auto-
oxidation) and overcomes problems encountered when deriving
the concentration of GSSG from ‘total GSH’. The procedure was
applied to the determination of GSH and GSSG in cultured
muscle cells and the trends in the absolute concentrations of these
analytes were rationalised by considering intracellular ROS in
conjunction with measures of cell viability. The results of this
study also highlight the importance of the GSH/GSSG ratio
(requiring precise quantification of both GSH and GSSG) to
assess the overall intracellular redox environment.
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